CTS EVENTIM signs joint venture with Zappa to become Israel s ticketing marketing leader
DGAP-News: CTS Eventim AG & Co. KGaA / Key word(s): Joint Venture
CTS EVENTIM signs joint venture with Zappa to become Israel s ticketing marketing leader
18.02.2021 / 15:00
Press Release
CTS EVENTIM signs joint venture with Zappa to become Israel s ticketing marketing leader
Munich/Tel Aviv, 18 February 2021. CTS EVENTIM, one of the leading international providers of ticketing services and live entertainment, is expanding its business operations in Israel and, by signing a joint venture with the Zappa Group, is taking the lead in the country s ticketing market.
The Zappa Group is the most important local promoter of live events, including a dozen popular festivals, and operates venues in Israel that seat up to 15,000. The partnership gives Zappa access to CTS EVENTIM s wide range of eCommerce marketing tools and powerful technologies, such as data analytics or the web shop for ticket sa
VARTA AG: VARTA AG exceeds guidance, announces first-ever dividend payments and presents new brand identity
18.02.2021 / 07:00
VARTA AG exceeds guidance, announces first-ever dividend payments
and presents new brand identity
Highly dynamic growth of around 140% in Group revenue to approximately ? 870m
Adjusted EBITDA rises by roughly 145% to approximately ? 239m
Adjusted EBITDA margin improves to around 27.5%
Microbatteries & Solutions records very strong fiscal year performance
Very positive development in the Household Batteries segment
Start of dividend payments: roughly ? 100m to be paid out
Promising outlook for 2021: organic growth in revenue and profit again on the cards for fiscal year 2021
Audited financial statements for 2020 to be published on 31
Seelos Therapeutics, Inc. a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, announced today an amendment of the agreement with Vyera Pharmaceuticals AG for the development of SLS-002 to repurchase in cash a significant portion of the royalties payable on any future net sales of SLS-002. On March 6, 2018 Seelos entered into an .
Airtel appoints Neeraj Jha as Head of CorpComm and Corporate Affairs adgully.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from adgully.com Daily Mail and Mail on Sunday newspapers.
Seelos Therapeutics : Announces Amendment of SLS-002 Agreement to Repurchase a Significant Portion of Royalties for SLS-002 (Intranasal Racemic Ketamine Program) marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.